The relationship between news on the COVID-19 pandemic through social media, feelings of fear and anxiety, and behavior.
FDA adcomm votes unanimously in favor of full approval for Eisai’s new Alzheimer’s drug
The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee on Friday voted 6-0 in favor of fully approving Eisai and Biogen’s Alzheimer’s drug Leqembi